china new digital currency 2020 Top People also ask

The American medical insurance giant said that the suspect who assassinated its CEO was not a company customer. A spokesman for UnitedHealth Group said that Luigi Mangione, the suspect accused of killing Brian Thompson, CEO of the company's United Health Care, was not a member of the company's insurance plan. Unitedhealth group said that Man Ghione and his mother were not members of United Health Insurance Company, and refuted the claim that the shooting incident was caused by dissatisfaction caused by his special experience in the company.The leading enterprises in the quantum science and technology sector are competing for layout. Recently, the quantum science and technology sector has been active. Since September 24, the concept index of the straight flush quantum science and technology has risen by more than 60%, and the stock prices of many stocks have doubled. Among A-share listed companies, many companies including China Mobile, China Telecom, Guo Dun Quantum, Hexin Instrument, Guoxin Technology and Geer Software have already laid out in the field of quantum technology. In terms of future market potential, ICVTA&K, a scientific and technological consulting organization, predicts that in 2023, the overall market size of the global quantum industry may reach 7.24 billion US dollars. However, the current quantum technology industry is still in the stage of research and development and industrial exploration. Taking quantum computing as an example, Guo Dun Quantum said in a survey conducted by an organization on November 15th that quantum computers have only achieved quantum superiority in some specific problems at present, and it is estimated that it will take about 5 to 10 years to surpass classical computing power in practical and valuable problems in the future. (Economic Information Daily)After the release of the Bank of Japan's short-term report, the yen rose slightly.

Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.Guotai Junan: It is suggested that the beauty care sector with product and channel changes and flexibility should be optimized from the bottom up. Guotai Junan said that after the pressure of consumption in 2022 and the destocking of consumers in 2023, the beauty consumption will return to the normal purchase cycle in 2024, and the industry prosperity will improve month-on-month, and the double-digit growth of online beauty will be achieved. However, after the channel dividend subsided, the platform traffic and price competition became fierce, and the brand differentiation further intensified. Relying on the product innovation and channel operation ability brought by organizational efficiency, the performance of domestic products in the head is still bright, and the rise of new domestic products has spread from beauty cosmetics to personal care. Looking forward to 2025, the market risk appetite will be significantly restored. Because of its many changes and the rising trend of domestic products as a whole, the American nursing sector has obvious growth attributes and significantly benefited from its style. Brand differentiation in the fundamental dimension has intensified, and it is suggested that the flexible target with product and channel changes should be optimized from bottom to top.Senior Advisor of Shi Pomao: Japan must be prepared for Trump tariffs. One of Japan's top security officials said that Japan needs to be prepared for the threat of US President-elect Trump to impose tariffs on Canada and Mexico, and adjust the supply chain to reduce the collateral damage to Japanese enterprises. Akihisa Nagashima, national security adviser to Japanese Prime Minister Shi Pomao, said that during his recent visit to the United States, he had a "frank" communication with Trump team members on tariff issues. "I realized that Japan must be ready for Trump to implement his plan," he said.

The market demand for large-size OLEDs has significantly improved, and the industrial chain has made great efforts to break through bottlenecks such as materials. According to the Securities Daily, on December 12th, Huawei Technologies Co., Ltd. officially launched the new MatePad Pro, which uses a 13.2-inch large-size flexible OLED screen. "In recent years, the application scenarios of OLED screens have become more and more extensive, especially the application of large-size OLED screens has shown a rapid growth trend, which will drive the relevant needs of the industrial chain." Ding Bingzhong, a partner of Shanghai Jimao Asset Management Co., Ltd., said in an interview. In the industry's view, the shipments of large-size OLED panels are rising, mainly due to the growing demand for artificial intelligence, games and high-end laptops. The continuous expansion of large-size OLED applications will also drive the demand for OLED materials to increase. "It should be noted that at present, China's OLED materials have not been fully localized, especially the localization rate of terminal materials is still relatively low." Ding Bingzhong said.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.Zhou Hongchun, a researcher at the State Council Development Research Center: Cultivating green buildings will form a new economic growth point. The Central Economic Work Conference proposed to jointly promote carbon reduction, pollution reduction and green growth, and step up the comprehensive green transformation of economic and social development. In this regard, Zhou Hongchun, a researcher at the the State Council Development Research Center, said that reducing carbon, reducing pollution and expanding green growth is the proper logic for China's high-quality economic development. The essence is to strengthen systematic thinking, pay attention to the coordination of various policies and reform and opening-up measures, and realize the green transformation and sustainable development of China's economy and society.